Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-058537
Filing Date
2010-03-16
Accepted
2010-03-16 17:06:39
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2036754
2 EXECUTIVE EMPLOYMENT AGREEMENT dex1029.htm EX-10.29 214557
3 CODE OF ETHICS FOR CEO, CFO AND SVP FINANCE dex141.htm EX-14.1 6889
4 GUIDE OF BUSINESS CONDUCT dex142.htm EX-14.2 68026
5 LIST OF WORLDWIDE SUBSIDIARIES dex21.htm EX-21 12990
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1503
7 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10739
8 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10724
9 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 5249
10 GRAPHIC g35134g08v25.jpg GRAPHIC 10632
11 GRAPHIC g35134g12n83.jpg GRAPHIC 45417
  Complete submission text file 0001193125-10-058537.txt   2446197
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30334 | Film No.: 10686274
SIC: 3841 Surgical & Medical Instruments & Apparatus